Against Sale of Cipla’s Copy of Novartis’: ‘Onbrez’
Cipla from manufacturing and selling a generic version of Novartis’ patented respiratory drug ‘INDACATEROL’(sold as ‘Onbrez’).The judgment is significant in that it acknowledges ‘public interest’ as a separate factor to be considered for grant of an interim injunction, although it was found to play no role in the case. The court rejected Cipla’s ‘public interest’ argument [...]